Management of Guillain–Barré syndrome with plasmapheresis or immunoglobulin: our experience from a tertiary care institute in South India-Reference-Cited by-同舟云学术

Management of Guillain–Barré syndrome with plasmapheresis or immunoglobulin: our experience from a tertiary care institute in South India

Published:2014-03-04 Issue:5 Volume:36 Page:732-736
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Kishore C. Krishna,Vijayabhaskar J.,Vishnu Vardhan R.,Sainaresh V.V.,Sriramnaveen P.,Sridhar A.V.S.S.N.,Varalaxmi B.,Sandeep P.,Ram R.,Vengamma B.,Siva Kumar V.

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0886022X.2014.890859

Reference22 articles.

1. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome

2. Evidence-Based Review of Therapeutic Plasma Exchange in Neurological Disorders

3. Plasmapheresis and acute Guillain-Barre syndrome

4. PROGNOSIS IN GUILLAIN-BARRÉSYNDROME

5. CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHY

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Efficacy of Plasmapheresis Versus Intravenous Immunoglobulin in Guillain-Barré Syndrome Management: A Systematic Review;Cureus;2024-03-27

2. Guillain–Barre syndrome: small-volume plasmapheresis versus intravenous immunoglobulin—3rd level hospital experience;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2024-03-19

3. Long-term outcomes of plasma exchange versus intravenous immunoglobulin for the treatment of Guillain-Barré Syndrome: A double-blind, randomized clinical trial;Restorative Neurology and Neuroscience;2024-02-15

4. Comparison of IVIg and TPE efficacy in the treatment of neurological disorders: a systematic literature review;Therapeutic Advances in Neurological Disorders;2023-01

5. Epidemiological and clinical characteristics of critically ill patients with Guillain-Barre syndrome in Shiraz, Iran;2022-11-11